Silphium Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Silphium Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200,000	Closed	-$23.1M	–	73
2023 Q3	$23.1M	Buy	200,000 +35,000	+21%	+$3.76M	7.53%	3
2023 Q2	$17M	Buy	165,000 +15,000	+10%	+$1.58M	8.42%	2
2023 Q1	$16.4M	Buy	150,000 +10,000	+7%	+$1.11M	13.84%	2
2022 Q4	$15.9M	Buy	+140,000	New	+$11.6M	15.93%	1

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return